ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Epichemist
|
750 |
288K |
3 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
750
|
288K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Shorts - general info
|
|
Epichemist
|
750 |
288K |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
750
|
288K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
9.9K |
4.4M |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Neuren completes enrolment in Pitt Hopkins Phase 2 trial
|
|
Epichemist
|
92 |
40K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
92
|
40K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Trofinetide accepted for Priority Review by Health Canada
|
|
Epichemist
|
8 |
4.3K |
11 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
8
|
4.3K
|
11
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Quarterly Activities Report
|
|
Epichemist
|
100 |
32K |
1 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
100
|
32K
|
1
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Quarterly Activities Report
|
|
Epichemist
|
100 |
32K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
100
|
32K
|
1
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Quarterly Activities Report
|
|
Epichemist
|
100 |
32K |
2 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
100
|
32K
|
2
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Epichemist
|
2.6K |
640K |
8 |
21/04/24 |
21/04/24 |
ASX - By Stock
|
2.6K
|
640K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Media
|
|
Epichemist
|
233 |
81K |
5 |
20/04/24 |
20/04/24 |
ASX - By Stock
|
233
|
81K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
9.9K |
4.4M |
26 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
26
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Quarterly Activities Report
|
|
Epichemist
|
100 |
32K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
100
|
32K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Recent Departures
|
|
Epichemist
|
13 |
4.4K |
3 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
4.4K
|
3
|
|
ASX - By Stock
|
CUV |
Re:
Recent Departures
|
|
Epichemist
|
13 |
4.4K |
7 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
13
|
4.4K
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
9.9K |
4.4M |
7 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
7
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Change to executive management
|
|
Epichemist
|
7 |
2.7K |
8 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
7
|
2.7K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
369 |
126K |
9 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
369
|
126K
|
9
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
369 |
126K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
369
|
126K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
369 |
126K |
3 |
14/04/24 |
14/04/24 |
ASX - By Stock
|
369
|
126K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
9.9K |
4.4M |
20 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
20
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
369 |
126K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
369
|
126K
|
3
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
369 |
126K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
369
|
126K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
369 |
126K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
369
|
126K
|
6
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
369 |
126K |
4 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
369
|
126K
|
4
|
|
ASX - By Stock
|
CUV |
Re:
Ann: Update - Notification of buy-back - CUV
|
|
Epichemist
|
8 |
2.0K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
8
|
2.0K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
Epichemist
|
316 |
159K |
8 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
316
|
159K
|
8
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
369 |
126K |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
369
|
126K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Epichemist
|
422 |
189K |
20 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
422
|
189K
|
20
|
|
ASX - By Stock
|
BGL |
Re:
Latest BGL media coverage
|
|
Epichemist
|
58 |
25K |
0 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
58
|
25K
|
0
|
|
ASX - By Stock
|
BGL |
Re:
Latest BGL media coverage
|
|
Epichemist
|
58 |
25K |
5 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
58
|
25K
|
5
|
|
ASX - By Stock
|
BGL |
Re:
Latest BGL media coverage
|
|
Epichemist
|
58 |
25K |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
58
|
25K
|
4
|
|
ASX - By Stock
|
AVH |
Re:
Don't consider selling before profitability
|
|
Epichemist
|
369 |
126K |
7 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
369
|
126K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Chart Thread
|
|
Epichemist
|
160 |
47K |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
160
|
47K
|
1
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Becoming a substantial holder
|
|
Epichemist
|
20 |
7.9K |
7 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
20
|
7.9K
|
7
|
|
ASX - By Stock
|
EYE |
Re:
ASCRS - The Beginning of Greatness!
|
|
Epichemist
|
32 |
9.8K |
10 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
32
|
9.8K
|
10
|
|
ASX - By Stock
|
BGL |
Re:
Charts!
|
|
Epichemist
|
653 |
299K |
5 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
653
|
299K
|
5
|
|
ASX - By Stock
|
CUV |
Re:
Disc Medicine - Best comparison stock to Clinuvel
|
|
Epichemist
|
91 |
34K |
6 |
02/04/24 |
02/04/24 |
ASX - By Stock
|
91
|
34K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Daily happenings?.
|
|
Epichemist
|
471 |
201K |
20 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
471
|
201K
|
20
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
Epichemist
|
91 |
51K |
56 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
91
|
51K
|
56
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
9.9K |
4.4M |
6 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
6
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Epichemist
|
2.6K |
640K |
9 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
2.6K
|
640K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
Epichemist
|
9.9K |
4.4M |
11 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
11
|
|
ASX - By Stock
|
CUV |
Re:
Ann: CLINUVEL Newsletter II - March 2024
|
|
Epichemist
|
20 |
6.8K |
3 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
20
|
6.8K
|
3
|
|
ASX - By Stock
|
BGL |
Re:
Ann: High-grade shoots identified at Deacon
|
|
Epichemist
|
39 |
17K |
5 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
39
|
17K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Epichemist
|
422 |
189K |
14 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
422
|
189K
|
14
|
|
ASX - By Stock
|
EYE |
Re:
Nova Eye Medical (EYE) Discussion
|
|
Epichemist
|
2.6K |
640K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
2.6K
|
640K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Upcoming Phase 2 Trial Announcement Dates
|
|
Epichemist
|
7 |
3.7K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
7
|
3.7K
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
Epichemist
|
422 |
189K |
12 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
422
|
189K
|
12
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
Epichemist
|
946 |
471K |
30 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
946
|
471K
|
30
|
|
ASX - By Stock
|
BGL |
Re:
Ann: Becoming a substantial holder
|
|
Epichemist
|
13 |
4.3K |
1 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
13
|
4.3K
|
1
|
|